CClinicalTrials.gg
RecruitingNCT05955859Updated Jul 27, 2023

Diagnostics of Mycotic Sinusitis in ENT Patients

An interventional study of Samplings from patient's affected paranasal sinus in Fungal Sinusitis, sponsored by University Hospital Ostrava. Recruiting at 1 site in Czechia. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-07-27.

Sponsored by University Hospital Ostrava · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Mycotic sinusitis is a rare inflammatory disease of the paranasal sinuses. In recent years, its occurrence is increasing. Due to this situation, mycotic sinusitis is gaining importance, even though most cases of mycotic sinusitis are limited on paranasal sinuses.

Non-invasive forms of mycotic sinusitis are divided into mycetoma and allergic mycotic sinusitis. Mycetoma (fungus ball) usually affects only one paranasal sinus, most often maxillary sinus. The predisposing factors which participate on development of mycotic sinusitis are not exactly known. Some factors are considered as possible predisposing factors, for example deviation of nasal septum, dental treatment of upper jaw teeth or changes of nasal microbiome.

The diagnosis of fungal sinusitis is problematic. With the increasing number of patients, it is essential to improve the diagnostic process. In present, suspicion of mycotic sinusitis is based on the patient's clinical symptoms and the endoscopic findings in the nasal cavity. Only in some cases nonspecific findings can be observed, such as smelly secretions from the nose, feeling of stuffy nose and pain over the affected sinus. Some patients may be completely asymptomatic, and only in some cases fungal masses can be observed in the nasal cavity. Computed tomography (CT) scans are gaining more and more importance. Typical sign of an affected sinus is obfuscation on CT scan but this sign is not specific for mycotic infection. Central hyperdense foci are also present in some patients, but they are also not specific and can imitate a foreign body. Identifying specific signs on CT scan could help with diagnosing mycotic sinusitis.

Read the detailed description

To identify specific determining signs for the diagnosis of fungal sinusitis, patients will undergo a series of examinations listed below.

  1. Entrance ear, nose, throat (ENT) examination

    • anamnesis (nasal secretion, nasal obstruction, nose injury, dental procedures on the teeth of the upper jaw, immune disorder)
    • rhinological questionnaires (SNOT-22, rhinoVAS, NOSE score, olfactory questionnaire)
    • ENT examination without endoscope: deviation of the nasal septum or hypertrophy of the nasal conchae, pathological secretion from the nose
    • endoscopic examination of the nose: pathological secretion in the nasal cavity or from the orifice of the sinuses, the presence of fungal masses in the nasal cavity, obstruction of the orifice of the sinuses, the edge of the nasal septum
  2. Computed tomography (CT) examination of the paranasal sinuses

    • evaluation of images in the frontal, sagittal and transverse planes
    • criteria of the affected cavity - complete/partial obscuration of the paranasal sinuses, hyperdense core, usuration or thickening of the bone of the paranasal sinuses
    • anatomical conditions of the nose and paranasal sinuses - the presence of septal deviation, dental pathology, Onodi's cellar, Haller's cellar, lateral recess of the sphenoid sinus
  3. Functional endonasal endoscopic surgery (FESS)

    • method of execution performance of functional endonasal endoscopic surgery - only the affected cavity is being operated, complete cleaning of the affected cavity
    • sampling during surgery (4 in total): two samples for histological examination (sample 1 - mycotic material, sample 2 - mucous of the affected paranasal sinus), sample 3 - mycotic material for culture examination of fungi, sample 4 - mycotic material for elemental analysis using electron microscopy .
  4. postoperative sample analysis

    • elemental analysis (sample 4): before analysis - control X-ray examination of the sample, the presence of hyperdense material on the X-ray image, performing electron microscopy, according to the structure of element evaluation.
    • histological examination (sample 1 and 2): evaluation of the sample 2 - mucosa of the paranasal sinuses - the presence of fungal invasion into the mucosa, inflammatory cellulization in the mucosa, evaluation of the sample 1 (mycotic material) - the presence of hyphae, inflammatory cellulization, calcification.
    • culture examination (sample 3): evaluation of the cultured finding by a microbiologist
02

Conditions studied

  • Fungal Sinusitis

Browse trials for

Keywords

  • Sinusitis
  • Mycosis
  • Paranasal sinus
03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age ≥ 18 years
  • patients with unilateral obfuscation of the paranasal sinus and patients with unilateral discharge from the nasal cavity

Exclusion criteria

Exclusion Criteria:

  • serious illness (decompensation phase) - cardiac, liver, kidney disease, can-cer
  • serious psychiatric illnesses
  • pregnancy
  • high operative risk according to The American Society of Anesthesiologists (ASA) ≥ IV
  • disagreement with participation in the study
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
65 participants (estimated)

Study arms

  • Experimental
    Patient with clinical suspicion of mycotic sinusitis

    Patient with clinical suspicion of mycotic sinusitis will undergo an examination as listed in Detailed Description.

    Procedure: Samplings from patient's affected paranasal sinus

Interventions

  • ProcedureSamplings from patient's affected paranasal sinus

    Samplings from patient's affected paranasal sinus during endoscopic surgery.

05

What researchers measure

Primary outcomes

  1. Computer tomography (CT) examination of the paranasal sinuses - images

    Evaluation of images in the frontal, sagittal and transverse planes - condition assessment.

    Time frame: 3 years

  2. Computer tomography (CT) examination of the paranasal sinuses - criteria

    Evaluation of criteria of the affected cavity - complete/partial obscuration of the paranasal sinuses, hyperdense core, usuration or thickening of the bone of the paranasal sinuses.

    Time frame: 3 years

  3. Computer tomography (CT) examination of the paranasal sinuses - anatomical conditions of the nose and paranasal sinuses

    Evaluation of anatomical conditions of the nose and paranasal sinuses - the presence of septal deviation, dental pathology, Onodi's cellar, Haller's cellar, lateral recess of the sphenoid sinus.

    Time frame: 3 years

  4. Entrance ENT examination - anamnesis

    Taking anamnesis from patients to summarize any nasal secretion, nasal obstruction, nose injury, dental procedures on the teeth of the upper jaw or immune disorder.

    Time frame: 3 years

  5. Entrance ENT examination - SNOT-22

    Sino-Nasal Outcome Test-22 (SNOT-22) Questionnaire - The patients will complete a list of symptoms and social/emotional consequences of their nasal disorder. The SNOT-22 is a validated scale that measures sinonasal symptoms in patients with sinusitis. The 22 questions are scored on a scale of 0-5 with a maximum total score of 110. Higher scores represent more symptomatic patients.

    Time frame: 3 years

  6. Entrance ENT examination - rhinoVAS

    Rhino Visual Analogue Scale (RhinoVAS) questionnaire will be used to assess postoperative changes in nasal function ranging from 0 (complete nose patency) to 10 cm (complete nose obstruction).

    Time frame: 3 years

  7. Entrance ENT examination - NOSE score

    A simple, five-question, validated Nasal Obstruction Symptom Evaluation (NOSE) instrument that uses a 20-point scale to capture breathing symptoms, with higher scores indicating more severe symptoms than lower scores. A score of 0 means no problems with nasal obstruction and a score of 100 means the worst possible problems with nasal obstruction.

    Time frame: 3 years

  8. Entrance ENT examination - olfactory questionnaire

    Olfactory questionnaire includes a short examination (test of identification and discrimination with perfumed markers) will be performed.

    Time frame: 3 years

  9. Entrance ENT examination - without endoscope

    Observation of deviation of the nasal septum or hypertrophy of the nasal concha, patho-logical secretion from the nose.

    Time frame: 3 years

  10. Entrance ENT examination - endoscopic examination

    Endoscopic examination of the nose in order to find any pathological secretion in the nasal cavity or from the orifice of the sinuses, the presence of fungal masses in the nasal cavity, obstruction of the orifice of the sinuses, the edge of the nasal septum.

    Time frame: 3 years

  11. Functional endonasal endoscopic surgery (FESS) - sample 1

    Mycotic material (as sample 1) for histological examination will be taken from patient´s affected cavity during FESS.

    Time frame: 3 years

  12. Functional endonasal endoscopic surgery (FESS) - sample 2

    Mucous of the affected paranasal sinus (as sample 2) for histological examination will be taken from patient´s affected cavity during FESS.

    Time frame: 3 years

  13. Functional endonasal endoscopic surgery (FESS) - sample 3

    Mycotic material for culture examination of fungi (as sample 3) will be taken from patient´s affected cavity during FESS.

    Time frame: 3 years

  14. Functional endonasal endoscopic surgery (FESS) - sample 4

    Mycotic material for elemental analysis using electron microscopy (as sample 4) will be taken from patient´s affected cavity during FESS.

    Time frame: 3 years

  15. Postoperative sample analysis - histological examination of sample 1

    Evaluation of the sample 1 (mycotic material) will be done to find out the presence of hyphae, inflammatory cellulization, calcification.

    Time frame: 3 years

  16. Postoperative sample analysis - histological examination of sample 2

    Evaluation of the sample 2 (mucosa of the paranasal sinuses) will be done to find out the presence of fungal invasion into the mucosa, inflammatory cellulization in the mucosa.

    Time frame: 3 years

  17. Postoperative sample analysis - culture examination of sample 3

    Evaluation of the cultured finding will be done by a microbiologist.

    Time frame: 3 years

  18. Postoperative sample analysis - elemental analysis of sample 4

    Control X-ray examination of the sample will be taken before analysis to find out the presence of hyperdense material on the X-ray image. Performing electron microscopy, according to the structure of ele-ment evaluation.

    Time frame: 3 years

06

Study locations

1 of 1 sites recruiting
  • University Hospital Ostrava, Department of Otorhinolaryngology and Head and Neck Surgery
    Ostrava, Czech Republic 70852, Czechia
    • Jiří Hynčica · Contact · jiri.hyncica@fno.cz · 0042059737
    • Simona Polášková, MD · Principal investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: No — There is no plan to share individual participant data with other researchers.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05955859
Lead sponsor
University Hospital Ostrava
Responsible party
Sponsor
First posted
Jul 21, 2023
Start date
May 2, 2023
Primary completion
Dec 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 27, 2023

Study contacts

Jiří Hynčica
Contact
jiri.hyncica@fno.cz
0042059737 ext. 2587
Simona Polášková, MD
principal investigator · University Hospital Ostrava
Petr Matoušek, MD, Ph.D.
study chair · University Hospital Ostrava
Michaela Masárová, MD
study chair · University Hospital Ostrava
Pavel Komínek, Prof., MD, Ph.D.
study chair · University Hospital Ostrava

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion